Billionaire Herriot Tabuteau's Axsome wins FDA acceptance for narcolepsy drug
The FDA has accepted a narcolepsy drug from Axsome Therapeutics, the biotech built by Haitian-born billionaire Herriot Tabuteau, with a decision due in May 2027.
Narcolepsy drug